Format
Sort by
Items per page

Send to

Choose Destination

Best matches for The Association of Genetic Factors to Multiple Sclerosis Susceptibility:

A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches. Bashinskaya VV et al. Hum Genet. (2015)

Multiple sclerosis: genetics, biomarkers, treatments. Axisa PP et al. Curr Opin Neurol. (2016)

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update. Ascherio A et al. Semin Neurol. (2016)

Search results

Items: 1 to 20 of 537

1.

Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.

Afrasiabi A, Parnell GP, Fewings N, Schibeci SD, Basuki MA, Chandramohan R, Zhou Y, Taylor B, Brown DA, Swaminathan S, McKay FC, Stewart GJ, Booth DR.

Genome Med. 2019 Apr 30;11(1):26. doi: 10.1186/s13073-019-0640-z.

2.

IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis.

von Essen MR, Søndergaard HB, Petersen ERS, Sellebjerg F.

Cells. 2019 Mar 26;8(3). pii: E285. doi: 10.3390/cells8030285.

3.

Correlation Between Smoking and Passive Smoking with Multiple Sclerosis and the Underlying Molecular Mechanisms.

Wang Z, Xie J, Wu C, Xiao G.

Med Sci Monit. 2019 Jan 31;25:893-902. doi: 10.12659/MSM.912863. Review.

4.

KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.

Rizzo R, Bortolotti D, Gentili V, Rotola A, Bolzani S, Caselli E, Tola MR, Di Luca D.

J Alzheimers Dis. 2019;67(4):1379-1389. doi: 10.3233/JAD-180777.

PMID:
30689576
5.

Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.

Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos LF.

PLoS Genet. 2019 Jan 17;15(1):e1007808. doi: 10.1371/journal.pgen.1007808. eCollection 2019 Jan.

6.

Association of SHMT1, MAZ, ERG, and L3MBTL3 Gene Polymorphisms with Susceptibility to Multiple Sclerosis.

Nazari Mehrabani SZ, Shushizadeh MH, Abazari MF, Nouri Aleagha M, Ardalan A, Abdollahzadeh R, Azarnezhad A.

Biochem Genet. 2018 Nov 19. doi: 10.1007/s10528-018-9894-1. [Epub ahead of print]

PMID:
30456721
7.

Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.

Simsek H, Geckin H, Sensoz NP, List EO, Arman A.

J Mol Neurosci. 2019 Jan;67(1):38-47. doi: 10.1007/s12031-018-1205-0. Epub 2018 Nov 16.

PMID:
30443838
8.

Familial association of attention-deficit hyperactivity disorder with autoimmune diseases in the population of Sweden.

Li X, Sjöstedt C, Sundquist J, Zöller B, Sundquist K.

Psychiatr Genet. 2019 Apr;29(2):37-43. doi: 10.1097/YPG.0000000000000212.

PMID:
30407269
9.

Replication study of GWAS risk loci in Greek multiple sclerosis patients.

Hadjigeorgiou GM, Kountra PM, Koutsis G, Tsimourtou V, Siokas V, Dardioti M, Rikos D, Marogianni C, Aloizou AM, Karadima G, Ralli S, Grigoriadis N, Bogdanos D, Panas M, Dardiotis E.

Neurol Sci. 2019 Feb;40(2):253-260. doi: 10.1007/s10072-018-3617-6. Epub 2018 Oct 26.

PMID:
30361804
10.

Heterogeneity in association of remote herpesvirus infections and pediatric MS.

Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E; US Network of Pediatric MS Centers.

Ann Clin Transl Neurol. 2018 Sep 17;5(10):1222-1228. doi: 10.1002/acn3.636. eCollection 2018 Oct.

11.

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

Gil-Varea E, Urcelay E, Vilariño-Güell C, Costa C, Midaglia L, Matesanz F, Rodríguez-Antigüedad A, Oksenberg J, Espino-Paisan L, Dessa Sadovnick A, Saiz A, Villar LM, García-Merino JA, Ramió-Torrentà L, Triviño JC, Quintana E, Robles R, Sánchez-López A, Arroyo R, Alvarez-Cermeño JC, Vidal-Jordana A, Malhotra S, Fissolo N, Montalban X, Comabella M.

J Neuroinflammation. 2018 Sep 14;15(1):265. doi: 10.1186/s12974-018-1307-1.

12.

Genome-wide association study in Guillain-Barré syndrome.

Blum S, Ji Y, Pennisi D, Li Z, Leo P, McCombe P, Brown MA.

J Neuroimmunol. 2018 Oct 15;323:109-114. doi: 10.1016/j.jneuroim.2018.07.016. Epub 2018 Aug 2.

PMID:
30196823
13.

CYP27A1, CYP24A1, and RXR-α Polymorphisms, Vitamin D, and Multiple Sclerosis: a Pilot Study.

Agnello L, Scazzone C, Lo Sasso B, Ragonese P, Milano S, Salemi G, Ciaccio M.

J Mol Neurosci. 2018 Sep;66(1):77-84. doi: 10.1007/s12031-018-1152-9. Epub 2018 Aug 7.

PMID:
30088172
14.

Protective C allele of the single-nucleotide polymorphism rs1335532 is associated with strong binding of Ascl2 transcription factor and elevated CD58 expression in B-cells.

Mitkin NA, Muratova AM, Korneev KV, Pavshintsev VV, Rumyantsev KA, Vagida MS, Uvarova AN, Afanasyeva MA, Schwartz AM, Kuprash DV.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3211-3220. doi: 10.1016/j.bbadis.2018.07.008. Epub 2018 Jul 10.

PMID:
30006149
15.

A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.

Estrada K, Whelan CW, Zhao F, Bronson P, Handsaker RE, Sun C, Carulli JP, Harris T, Ransohoff RM, McCarroll SA, Day-Williams AG, Greenberg BM, MacArthur DG.

Nat Commun. 2018 May 16;9(1):1929. doi: 10.1038/s41467-018-04332-3.

16.

Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk.

Wang XX, Chen T.

Immunol Invest. 2018 Jul;47(5):431-442. doi: 10.1080/08820139.2018.1425699. Epub 2018 Apr 12.

PMID:
29648897
17.

The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population.

Čierny D, Lehotský J, Kantorová E, Sivák Š, Javor J, Kurča E, Dobrota D, Michalik J.

Neurol Res. 2018 Jul;40(7):607-614. doi: 10.1080/01616412.2018.1456711. Epub 2018 Apr 5.

PMID:
29619906
18.

Role of gene polymorphisms in vitamin D metabolism and in multiple sclerosis.

Elkama A, Karahalil B.

Arh Hig Rada Toksikol. 2018 Mar 1;69(1):25-31. doi: 10.2478/aiht-2018-69-3065. Review.

PMID:
29604195
19.

The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study.

Křenek P, Benešová Y, Bienertová-Vašků J, Vašků A.

J Mol Neurosci. 2018 Apr;64(4):559-566. doi: 10.1007/s12031-018-1034-1. Epub 2018 Mar 28.

PMID:
29589202
20.

Variant of EOMES Associated with Increasing Risk in Chinese Patients with Relapsing-remitting Multiple Sclerosis.

Chen S, Zhang J, Liu QB, Zhuang JC, Wu L, Xu YF, Li HF, Wu ZY, Xiao BG.

Chin Med J (Engl). 2018 Mar 20;131(6):643-647. doi: 10.4103/0366-6999.226892.

Supplemental Content

Loading ...
Support Center